OncXerna Therapeutics Company

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

Last Funding Type: Series B
Funding Status: Early Stage Venture
Headquarters: Waltham, Massachusetts, United States
Founded Date: 2018-01-01
Total Funding: 96500000
Employee Number: 11-50
Industry: Gene therapy